Abstract
Seventy-six patients with advanced gastric adenocarcinoma were studied in a prospecitive, randmoised, controlled trial using vincristine, methotrexate, cyclophosphamide, and 5-fluorouracil in an initiation course and mitomycin-C with 5-fluorouracil as maintenance therapy. Thirty-seven patients were inoperable and 39 had the primary tumour resected with histological evidence of residual disease. Survival in the inoperable group was short and showed no significant difference between treated and control patients. The median survival times for treated and control groups were 9.5 and 9.0 weeks respectively. In the resected patients there was no difference in ultimate overall survival between the groups but up to 20 weeks there was a suggestion that the probability of survival in treated patients was higher (P = 0.06). The patients were well-matched and it is concluded that chemotherapy has had an early effect but that a further trial with more detailed stratification, particularly of staging and histological grade, is needed. No patient received treatment for longer than two years and unacceptable toxicity occurred in only two patients. Nausea occurred more frequently in the treated group but was short-lived and clinically manageable.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Comis R. L., Carter S. K. A review of chemotherapy in gastric cancer. Cancer. 1974 Nov;34(5):1576–1586. doi: 10.1002/1097-0142(197411)34:5<1576::aid-cncr2820340503>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
- Hawley P. R., Westerholm P., Morson B. C. Pathology and prognosis of carcinoma of the stomach. Br J Surg. 1970 Dec;57(12):877–883. doi: 10.1002/bjs.1800571202. [DOI] [PubMed] [Google Scholar]
- Imanaga H., Nakazato H. Rseults of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence. World J Surg. 1977 Mar;2(1):213–221. doi: 10.1007/BF01665086. [DOI] [PubMed] [Google Scholar]
- KARNOFSKY D. A. Meaningful clinical classification of therapeutic responses to anticancer drugs. Clin Pharmacol Ther. 1961 Nov-Dec;2:709–712. doi: 10.1002/cpt196126709. [DOI] [PubMed] [Google Scholar]
- Moertel C. G. Chemotherapy of gastrointestinal cancer. Clin Gastroenterol. 1976 Sep;5(3):777–793. [PubMed] [Google Scholar]
- Moertel C. G. Clinical management of advanced gastrointestinal cancer. Cancer. 1975 Aug;36(2):675–682. doi: 10.1002/1097-0142(197508)36:2+<675::aid-cncr2820360810>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
- Moertel C. G., Mittelman J. A., Bakemeier R. F., Engstrom P., Hanley J. Sequential and combination chemotherapy of advanced gastric cancer. Cancer. 1976 Aug;38(2):678–682. doi: 10.1002/1097-0142(197608)38:2<678::aid-cncr2820380209>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
- Nakajima T., Fukami A., Ohashi I., Kajitani T. Long-term follow-up study of gastric cancer patients treated with surgery and adjuvant chemotherapy with mitomycin C. Int J Clin Pharmacol Biopharm. 1978 May;16(5):209–216. [PubMed] [Google Scholar]
- Ohman U., Wetterfors J. Carcinoma of the stomach. Analysis of a clinical material and possible ways of improving the prognosis. Acta Chir Scand. 1970;136(3):219–226. [PubMed] [Google Scholar]
- Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Priestman T. J. Recent advances in cytotoxic therapy for gastrointestinal carcinoma: a review. J R Soc Med. 1978 Mar;71(3):195–198. doi: 10.1177/014107687807100308. [DOI] [PMC free article] [PubMed] [Google Scholar]